欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5282/002
药品名称Trabectedine Teva 1 mg, poeder voor concentraat voor oplossing voor infusie
活性成分
    • TRABECTEDIN 1.0 mg
剂型Powder for concentrate for solution for injection/infusion
上市许可持有人Teva B.V. Swensweg 5 2031 GA Haarlen Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Slovenia (SI)
    • Austria (AT)
    • Croatia (HR)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Germany (DE)
      Trabectedin-ratiopharm 1 mg Pulver zur Herstellung einer Infusionslösung
    • Hungary (HU)
    • Denmark (DK)
    • Romania (RO)
    • Belgium (BE)
    • Slovakia (SK)
许可日期2022/01/07
最近更新日期2024/01/10
药物ATC编码
    • L01CX01 trabectedin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase